Diametric Capital’s TELA Bio TELA Stock Holding History

Diametric Capital’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-35,755	Closed	-$108K	–	358
2024 Q4	$108K	Buy	+35,755	New	+$101K	0.07%	270

Other funds holding TELA

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Diametric Capital's TELA Position: Q1 2025 in Review

Diametric Capital sold out of TELA Bio (TELA) in Q1 2025, closing a stake of 35,755 shares — an estimated $108K sold.

Diametric Capital first reported a position in TELA in Q4 2024 and held it in 1 quarter. The position peaked at $108K in Q4 2024. 50 funds tracked by Wall St. Rank hold TELA as of Q1 2025.

Diametric Capital reported no remaining TELA Bio position as of Q1 2025 after selling out during the quarter.
Diametric Capital sold 35,755 TELA Bio shares in Q1 2025, an estimated $108K.
Diametric Capital first reported a position in TELA Bio in Q4 2024 and held it in 1 quarter.
Diametric Capital's TELA Bio position peaked at $108K in Q4 2024.
50 funds tracked by Wall St. Rank held TELA Bio as of Q1 2025.

Based on Diametric Capital's 13F filing for Q1 2025, filed 14 May 2025.